Home
>
National Drug Code (NDC)
>
Ciclopirox
Ciclopirox - 45802-141-67 - (Ciclopirox)
Drug Information of Ciclopirox
| Product NDC: | 45802-141 |
| Proprietary Name: | Ciclopirox |
| Non Proprietary Name: | Ciclopirox |
| Active Ingredient(s): | 2.9 g/6.6mL & nbsp; Ciclopirox |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ciclopirox
| Product NDC: | 45802-141 |
| Labeler Name: | Perrigo New York Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077623 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070919 |
Package Information of Ciclopirox
| Package NDC: | 45802-141-67 |
| Package Description: | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-141-67) > 6.6 mL in 1 BOTTLE, WITH APPLICATOR |
NDC Information of Ciclopirox
| NDC Code | 45802-141-67 |
| Proprietary Name | Ciclopirox |
| Package Description | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-141-67) > 6.6 mL in 1 BOTTLE, WITH APPLICATOR |
| Product NDC | 45802-141 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ciclopirox |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20070919 |
| Marketing Category Name | ANDA |
| Labeler Name | Perrigo New York Inc |
| Substance Name | CICLOPIROX |
| Strength Number | 2.9 |
| Strength Unit | g/6.6mL |
| Pharmaceutical Classes | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
